OC

Orion Capital Group, Inc.

North America, California, United States, Redwood City

Description

M&A Advisory and Investment Banking

Investor Profile

Orion Capital Group, Inc. has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Singapore.
  • Strong thematic focus on Biotechnology, Financial Services, FinTech.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United States (50%)
  • Singapore (50%)

Industry Focus

  • Biotechnology
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Orion Capital Group, Inc. frequently co-invest with?

DH
North America, California, United States, Beverly Hills
Co-Investments: 1
C-Bridge Capital
North America, New York, United States, New York
Co-Investments: 1
Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
SC
North America, New York, United States, New York
Co-Investments: 1
FI
North America, Texas, United States, San Antonio
Co-Investments: 1
Credit Saison
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Global Founders Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Ion Pacific
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1

What are some of recent deals done by Orion Capital Group, Inc.?

Chocolate Finance

Singapore, Central Region, Singapore

Chocolate Finance is a Sinagapore based fintech startup.

Financial ServicesFinTech
Series AAug 25, 2022
Amount Raised: $19,000,000
AffaMed Therapeutics

New City, New York, United States

AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.

Biotechnology
Series BMar 30, 2021
Amount Raised: $170,000,000